Skip to main content
Equibles
AYTU $2.02 -0.98%
AYTU logo
AYTU · Aytu Biopharma, Inc
Track AYTU — free

Use AYTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AYTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.02 -0.02 (-0.98%)
Rebalance outlook locked
Market Cap
$23.91M
Shares
10.87M
Volume · Oct 6 13.78K Avg daily vol (3M) 35.5K
All webcasts

Earnings call · FY2022 Q2

Aytu Biopharma, Inc (AYTU) Q2 2022 Earnings Call

Concluded Feb 14, 2022
Feb 14, 2022 0 turns
Period
FY2022 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $23.12M +52.7% YoY
Diluted EPS -$8.74
Gross margin 53.2% -5.5 pp YoY
Net income -$11.55M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 14, 2022 10-Q report Filed Feb 14, 2022

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Rx$14.64M
Consumer Health$8.48M
Full-screen source Call document

AYTU transcript alerts

Aytu Biopharma, Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →